APELLIS PHARMACEUTICALS INC

NASDAQ: APLS (Apellis Pharmaceuticals, Inc.)

Last update: 19 May, 10:35PM

17.67

0.22 (1.26%)

Previous Close 17.45
Open 17.24
Volume 2,440,056
Avg. Volume (3M) 2,511,177
Market Cap 2,220,801,024
Price / Sales 2.93
Price / Book 13.98
52 Weeks Range
16.10 (-8%) — 43.99 (148%)
Earnings Date 30 Jul 2025 - 4 Aug 2025
Profit Margin -28.83%
Operating Margin (TTM) -49.96%
Diluted EPS (TTM) -1.80
Quarterly Revenue Growth (YOY) -3.20%
Total Debt/Equity (MRQ) 285.94%
Current Ratio (MRQ) 4.08
Operating Cash Flow (TTM) -8.29 M
Levered Free Cash Flow (TTM) 45.63 M
Return on Assets (TTM) -14.20%
Return on Equity (TTM) -103.82%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Apellis Pharmaceuticals, Inc. Bearish Bearish

AIStockmoo Score

1.1
Analyst Consensus 1.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 3.5
Technical Oscillators -0.5
Average 1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
APLS 2 B - - 13.98
BBIO 8 B - - -
BPMC 8 B - - 24.23
CORT 8 B - 62.84 11.07
MDGL 7 B - - 9.46
TGTX 6 B - 146.88 24.57

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 13.77%
% Held by Institutions 104.51%
52 Weeks Range
16.10 (-8%) — 43.99 (148%)
Price Target Range
18.00 (1%) — 52.00 (194%)
High 52.00 (Raymond James, 194.28%) Buy
Median 29.00 (64.12%)
Low 18.00 (RBC Capital, 1.87%) Hold
Average 31.73 (79.57%)
Total 5 Buy, 6 Hold
Avg. Price @ Call 17.79
Firm Date Target Price Call Price @ Call
Morgan Stanley 02 Jul 2025 26.00 (47.14%) Hold 17.82
Wells Fargo 02 Jun 2025 29.00 (64.12%) Hold 19.14
08 May 2025 26.00 (47.14%) Hold 17.81
Citigroup 22 May 2025 41.00 (132.03%) Buy 17.78
Mizuho 14 May 2025 20.00 (13.19%) Hold 16.70
B of A Securities 09 May 2025 23.00 (30.16%) Hold 17.30
Raymond James 09 May 2025 52.00 (194.28%) Buy 17.30
Baird 08 May 2025 47.00 (165.99%) Buy 17.81
RBC Capital 08 May 2025 18.00 (1.87%) Hold 17.81
21 Apr 2025 21.00 (18.85%) Hold 18.03
Scotiabank 08 May 2025 20.00 (13.19%) Hold 17.81
Needham 07 May 2025 29.00 (64.12%) Buy 17.99
Cantor Fitzgerald 29 Apr 2025 44.00 (149.01%) Buy 18.21
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria